Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-037791
Filing Date
2021-06-03
Accepted
2021-06-03 17:30:17
Documents
1
Period of Report
2021-06-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4101
  Complete submission text file 0001209191-21-037791.txt   5521
Mailing Address 201 W 70TH ST, SUITE 23K NEW YORK NY 10023
Business Address
GRAY MARY ANN (Reporting) CIK: 0001261974 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39264 | Film No.: 21993734

Mailing Address 99 HAYDEN AVENUE, SUITE 120 (BLD E) LEDGEMONT TECHNOLOGY CENTER LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE, SUITE 120 (BLD E) LEDGEMONT TECHNOLOGY CENTER LEXINGTON MA 02421 617-513-8774
Keros Therapeutics, Inc. (Issuer) CIK: 0001664710 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations